Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TP 2021

Next Previous
X
Search
Drug Profile

TP 2021

Alternative Names: JT-09; JT-09 Implant; JT-09 ProNeura implants; TP-2021

Latest Information Update: 28 Jun 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator JT Pharmaceuticals
  • Developer JT Pharmaceuticals; Medical University of South Carolina
  • Class Analgesics; Antipruritics; Peptides; Skin disorder therapies
  • Mechanism of Action Opioid kappa receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Pruritus
  • No development reported Pain

Most Recent Events

  • 28 Jun 2023 No recent reports of development identified for preclinical development in Pain in USA (PO)
  • 19 Apr 2023 TP 2021 is available for licensing as of 19 Apr 2023. https://ir.titanpharm.com/
  • 23 Mar 2022 Titan Pharmaceuticals plans to file an IND application with the FDA in USA for Pruritus by March 2024

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top